Iceland· IS-890046
Synarela
A nafarelin product containing nafarelinum inn acetat, registered in Iceland by Pfizer ApS. The same ATC class is registered in 12 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Nafarelin is registered in 12 of 19 countries.
Countries holding a registration under ATC H01CA02 (nafarelin), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 6 of them publish a price we can compare per daily dose
Nafarelin · ATC H01CA02
12 / 19 countries
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- United Kingdom
- United Statesprice
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Nafarelinum INN acetat
- Manufacturer
- Pfizer ApS
- Country
- Iceland (IS)
- ATC code
- H01CA02
- ATC class
- Nafarelin
- Defined daily dose
- 0.4 mg, N
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 1
1 priced- ean1661658 ml x1 staukISK 19954
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Nafarelin in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NorwaySynarelPfizer
- FinlandSynarelaPfizer Oy
- SwedenSynarela 200 mikrogram/dos Nässpray, lösningOrifarm AB
- CzechiaSYNARELPfizer, spol. s r.o., Praha
- United KingdomSynarel 200micrograms/dose nasal sprayPfizer Ltd
- IrelandSynarel 200 micrograms/dose Nasal Spray SolutionPfizer Healthcare Ireland Unlimited Company
- NetherlandsSynarel, neusspray 200 microgram per dosisPfizer B.V.
- CanadaSYNARELPFIZER CANADA ULC
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Czechia · Synarel
- Germany · Synarela
- Denmark · Synarela
- Spain · Synarel
- Finland · Synarela
- France · Synarel
- United Kingdom (Northern Ireland) · Synarel
- Ireland · Synarel
- Netherlands · Synarel
- Norway · Synarela
- Sweden · Synarela
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/08ad3b3d-2027-4c52-b4b1-d139390e3848 GET /v1/drugs/08ad3b3d-2027-4c52-b4b1-d139390e3848?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Nefúði, lausn",
"source": "lyfjastofnun",
"atc_raw": "H01CA02",
"marketed": true,
"strength": "2 mg/ml",
"ma_number": "890046",
"substance": "Nafarelinum INN acetat",
"other_info": "Ávísun lyfsins er bundin við sérfræðinga í kvensjúkdómum.",
"legal_status": "(R Z) Sérfræðingsmerkt (og lyfseðilsskylt)",
"ma_issued_serial": "33695"
}See everything about nafarelin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.